From these results, it is concluded that immunofluorescence microscopy of clinically normal skin is a valuable diagnostic method which should be reconsidered as a potential criterion for the diagnosis of SLE in the next evaluation of the ARA criteria.
Immunofluorescence microscopy of clinically normal skin is considered to be a useful marker for systemic lupus erythematosus (SLE).
Positive results can be found before any other laboratory test in SLE.' In a 10 year prospective study it was found to detect a subgroup of patients with a worse prognosis.2 It has not been included as a criterion for the diagnosis by the American Rheumatism Association (ARA), however.3 In a multicentre study the sensitivity and specificity of the skin biopsy test were relatively high (68 and 81%), but the method was eliminated from the final data analysis as it was seldom performed.3
In 60-70% of patients with SLE, immunoglobulins and complement components (immunoreactants) are deposited in a band-like manner at the basal membrane zone of clinically healthy skin (the basal membrane phenomenon is referred to as the lupus band). ' These deposits (especially of the IgM type) are not specific for SLE as they can also be shown, though less often, in other systemic connective tissue diseases, such as mixed connective tissue disease (50%),4 rheumatoid arthritis (RA; 66%), 5 and primary Sjogren's syndrome (8%),6 and even in healthy control subjects (13-21% ).7-9 Smith et al observed increased specificity of immunofluorescence microscopy for SLE with the number of immunoreactants found at the basal membrane zone.'0 They did not consider the types, though it seems from their data that some (IgA, C3) were likely to be more specific than others (lgM).'0
Immunoreactants are often not distributed along the full length of the basal membrane zone, and therefore do not form a continuous lupus band. The implication ofthis phenomenon for the use of immunofluorescence microscopy as a diagnostic method in SLE has not yet been investigated. In addition, other features of immunofluorescence are also recognised in SLE-that is, epidermal nuclear IgG deposits (the in vivo antinuclear antibody staining phenomenon)" and deposits of immunoreactants in the blood vessel walls. [12] [13] [14] [15] The aim of this study was to investigate which variables or combination of variables in immunofluorescence microscopy of clinically normal skin are most useful in terms of specificity, sensitivity, predictive value, and efficiency for the diagnosis of SLE. We considered not only the presence of the deposits at the basal membrane zone, but also their complexity, their distribution along the basal membrane zone, the complexity and localisation of deposits in vessel walls, and the presence of the in vivo antinuclear antibody phenomenon. Furthermore, we examined whether skin immunofluorescence yields information additional to clinical and serological parameters in SLE, or whether it is merely a redundant method.
Patients and methods

PATIENTS
This study was of 297 patients who visited the outpatient clinics of the departments of rheumatology, immunopathology, or dermatology of the University Hospital Utrecht in 1987, and in whom, after informed consent, a biopsy sample of clinically healthy skin was taken. This study covered almost the same population as described previously. " The clinical, serological, and immunofluorescence data of all these patients were analysed.
Three groups of patients were formed: group I, 66 patients with SLE; group II, 81 patients with other LE forms; and group III, 150 patients with other systemic connective tissue diseases (table 1) . In these groups the mean Immunofluorescence microscopy of healthy skin in SLE (table 7) . From all blood parameters, only high titre serum antinuclear antibodies (p<005) and antibodies to double stranded DNA (0-05< p<O 10) were associated with an immunofluorescence variable-that is, IgG at the basal membrane zone (X2 test). The variation between these studies and between these and our present study may be due to the fact that smaller particles in vessel walls are easily overlooked. Deposits of IgA in the superficial vessels of clinically healthy skin have been shown to be a marker for IgA nephropathy, Henoch-Schonlein purpura, and alcoholic liver disease, but the fine granular particles seen in these disorders differ markedly from those in SLE.22 23 In addition, these deposits were also found in 6% of a large group of patients with diseases not related to these disorders or to SLE. The associations between IgG and IgA in the basal membrane zone and C3 in the blood vessels with malar rash, and between IgG at the basal membrane zone and light sensitivity, may point to a pathogenic relation. As these deposits were found in clinically normal skin, however, additional factors must play a part in the development of clinically manifest disease.
The immunofluorescence biopsy of clinically healthy forearm skin is a relatively simple method. When performed with the correct antiseptic measures, the wound heals without delay. In our hospital biopsy samples are taken satisfactorily by rheumatologists, internists, and dermatologists. From a technical point of view, the method is far less complicated than, for example, immunoblotting. We therefore see no reason why it should not be performed more regularly.
In the past, the diverse and complicated immunofluorescence patterns in SLE have been unduly reduced to the mere presence or absence of the lupus band. This study indicates that there is more than just the lupus band. Immunohistology of the skin, if performed as described here, can provide information not obtainable by other laboratory methods. Immunofluorescence microscopy of the skin therefore deserves to be considered seriously for inclusion as a diagnostic parameter for SLE, and should be reconsidered in an evaluation of the ARA criteria. 
